Verona Pharma PLC

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Verona Pharma PLC
TickerVRNA
CIK #0001657312
CUSIP925050106
SectorLife Sciences - Pharmaceutical Preparations
Address3 More London Riverside, London, SE1 2RE
Source [EDGAR]
CIK Filing 2011 - 2024
[0001657312] 10-K
[0001657312] 10-Q
[0001657312] 3
[0001657312] 4
[0001657312] 6-K
[0001657312] 8-K
[0001657312] D
[0001657312] SC 13D
[0001657312] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Perceptive Advisors LLC Verona Pharma PLC [2023-04-20] 5.6
Wellington Management Group LLP Verona Pharma PLC [2022-02-04] 8.34
RA Capital Management LP Verona Pharma PLC [2021-02-16] 9.99
Access Industries Holdings LLC Verona Pharma PLC [2020-07-24] 10.7
Novo Holdings A/S Verona Pharma PLC [2019-04-02] 13.21
Edmond de Rothschild Investment Partners Verona Pharma PLC [2017-05-12] 6.7
Novo A/S Verona Pharma PLC [2017-05-09] 14.0
Growth Equity Opportunities IV LLC Verona Pharma PLC [2017-05-09] 11.4
Abingworth LLP Verona Pharma PLC [2017-05-08] 8.6
venBio Global Strategic Fund II LP Verona Pharma PLC [2017-05-08] 7.1
OrbiMed Advisors LLC Verona Pharma PLC [2017-05-08] 11.8
Vivo Ventures VI LLC Verona Pharma PLC [2017-05-05] 2.8
Foresite Capital Fund III LP Verona Pharma PLC [2017-05-05] 5.0
Form 3/4/5 Filer 2011 - 2024
Verona Pharma plc
OrbiMed Advisors LLC
OrbiMed Capital GP VI LLC
Gupta Rishi
Hahn Mark W
Zaccardelli David
Poll Claire
Rickard Kathleen A.
Ullman Anders
Shah Mahendra
Edwards Martin
Ebsworth David R
Brady James Aloysius
Cunningham Kenneth
Sinha Vikas
Deschamps Lisa
Blavatnik Len
Access Industries Holdings LLC
Access Industries Management LLC
AI Biotechnology LLC
Sinclair Andrew
Baskett Forest
Florence Anthony A. Jr.
Makhzoumi Mohamad
Makower Joshua
Sandell Scott D
Sonsini Peter W.
Form 13F Holdings
Firm Period DFND Voting Shares
RA Capital Management LP [2023-03-31] SOLE 0.0 6,317,990.0
NEA Management Company LLC [2023-03-31] DFND 5,584,753.0 5,584,753.0
FMR LLC [2023-03-31] DFND 4,567,179.0 4,567,179.0
OrbiMed Advisors LLC [2023-03-31] SOLE 4,260,691.0 4,260,691.0
Vivo Capital LLC [2023-03-31] SOLE 4,249,918.0 4,249,918.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 3,291,473.0
Deep Track Capital LP [2023-03-31] SOLE 3,187,415.0 3,187,415.0
Fairmount Funds Management LLC [2023-03-31] SOLE 3,127,429.0 3,127,429.0
Frazier Life Sciences Management LP [2023-03-31] SOLE 2,944,349.0 2,944,349.0
Perceptive Advisors LLC [2023-03-31] SOLE 2,733,790.0 2,733,790.0
Octagon Capital Advisors LP [2023-03-31] SOLE 2,468,000.0 2,468,000.0
Carlyle Group Inc. [2023-03-31] DFND 0.0 2,457,500.0
Woodline Partners LP [2023-03-31] SOLE 1,744,264.0 1,744,264.0
Aisling Capital Management LP [2023-03-31] SOLE 1,115,352.0 1,115,352.0
Jennison Associates LLC [2023-03-31] DFND 1,028,998.0 1,028,998.0
Paradigm Biocapital Advisors LP [2023-03-31] SOLE 962,361.0 962,361.0
Nicholas Investment Partners LP [2023-03-31] SOLE 941,300.0 941,300.0
Avidity Partners Management LP [2023-03-31] SOLE 878,800.0 878,800.0
Samsara Biocapital LLC [2023-03-31] SOLE 695,001.0 695,001.0
Millennium Management LLC [2023-03-31] SOLE 550,762.0 550,762.0
Parkman Healthcare Partners LLC [2023-03-31] SOLE 487,995.0 487,995.0
Ally Bridge Group NY LLC [2023-03-31] SOLE 487,631.0 487,631.0
Affinity Asset Advisors LLC [2023-03-31] SOLE 452,821.0 452,821.0
Two Sigma Investments LP [2023-03-31] SOLE 404,981.0 404,981.0
Federated Hermes Inc [2023-03-31] DFND 402,050.0 402,050.0
Moody Aldrich Partners LLC [2023-03-31] SOLE 156,210.0 351,670.0
BlackRock Inc. [2023-03-31] SOLE 347,226.0 347,226.0
Schonfeld Strategic Advisors LLC [2023-03-31] SOLE 335,700.0 335,700.0
Citadel Advisors LLC [2023-03-31] DFND 299,448.0 299,448.0
Two Sigma Advisers LP [2023-03-31] SOLE 241,100.0 262,800.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com